JPMorgan Chase & Co’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-6,857
| Closed | -$26.6K | – | 6350 |
|
2023
Q4 | $26.6K | Sell |
6,857
-20,432
| -75% | -$79.3K | ﹤0.01% | 5179 |
|
2023
Q3 | $89.2K | Hold |
27,289
| – | – | ﹤0.01% | 4677 |
|
2023
Q2 | $87.3K | Buy |
27,289
+21,639
| +383% | +$69.2K | ﹤0.01% | 4692 |
|
2023
Q1 | $24.5K | Buy |
5,650
+5,000
| +769% | +$21.7K | ﹤0.01% | 5104 |
|
2022
Q4 | $3K | Hold |
650
| – | – | ﹤0.01% | 5292 |
|
2022
Q3 | $3K | Hold |
650
| – | – | ﹤0.01% | 5262 |
|
2022
Q2 | $2K | Hold |
650
| – | – | ﹤0.01% | 5403 |
|
2022
Q1 | $2K | Hold |
650
| – | – | ﹤0.01% | 5578 |
|
2021
Q4 | $2K | Hold |
650
| – | – | ﹤0.01% | 5579 |
|
2021
Q3 | $3K | Hold |
650
| – | – | ﹤0.01% | 5339 |
|
2021
Q2 | $3K | Hold |
650
| – | – | ﹤0.01% | 5336 |
|
2021
Q1 | $3K | Sell |
650
-296
| -31% | -$1.37K | ﹤0.01% | 5119 |
|
2020
Q4 | $3K | Sell |
946
-12
| -1% | -$38 | ﹤0.01% | 4755 |
|
2020
Q3 | $2K | Hold |
958
| – | – | ﹤0.01% | 4698 |
|
2020
Q2 | $3K | Sell |
958
-588
| -38% | -$1.84K | ﹤0.01% | 4599 |
|
2020
Q1 | $2K | Hold |
1,546
| – | – | ﹤0.01% | 4577 |
|
2019
Q4 | $5K | Sell |
1,546
-35,170
| -96% | -$114K | ﹤0.01% | 4569 |
|
2019
Q3 | $147K | Buy |
36,716
+28,280
| +335% | +$113K | ﹤0.01% | 3861 |
|
2019
Q2 | $29K | Buy |
8,436
+5,590
| +196% | +$19.2K | ﹤0.01% | 4442 |
|
2019
Q1 | $13K | Buy |
2,846
+1,300
| +84% | +$5.94K | ﹤0.01% | 4584 |
|
2018
Q4 | $6K | Sell |
1,546
-1,692
| -52% | -$6.57K | ﹤0.01% | 4680 |
|
2018
Q3 | $15K | Buy |
3,238
+2,342
| +261% | +$10.8K | ﹤0.01% | 4604 |
|
2018
Q2 | $3K | Hold |
896
| – | – | ﹤0.01% | 4678 |
|
2018
Q1 | $3K | Hold |
896
| – | – | ﹤0.01% | 4591 |
|
2017
Q4 | $2K | Hold |
896
| – | – | ﹤0.01% | 4597 |
|
2017
Q3 | $3K | Hold |
896
| – | – | ﹤0.01% | 4169 |
|
2017
Q2 | $1K | Buy |
+896
| New | +$1K | ﹤0.01% | 4257 |
|